60 likes | 80 Views
These days, Asia is likely to soon overtake North America in terms of overall pharma sales. This is a trend that is likely to continue due to broad macroeconomic drivers such as population and income growth. It is true is truly said that Japan and China will continue to dominate pharma sales in Asia. SEMPER FEDILIS work hard in this competitive world.
E N D
How to Build an Empire with SEMPER FEDILIS Structural changes in pharma Nowadays, global pharma market is going through major and crucial structural changes with significant implications for India and Indian companies. North America continues to be the largest pharma market in the world by contributing to about a third of the $1 trillion in annual global pharma sales in terms of Value. However, in last five years with the rapid pace of growth in pharma sales in Asia the expected growth in the medium-term future, the centre of gravity for the pharma market is slowly shifting toward Asia. These days, Asia is likely to soon overtake North America in terms of overall pharma sales. This is a trend that is likely to continue due to broad macroeconomic drivers such as population and income growth. It is true is truly said that Japan and China will continue to dominate pharma sales in Asia.SEMPER FEDILISwork hard in this competitive world.
Vision SEMPER FEDILIS vision states to be a commercially viable leading pharmaceutical company in providing quality products which is affordable to all sections in the society. SEMPER FEDILISendeavour is to be a front runner in the market by INNOVATION and PERSEVEARANCE in Pharma community.
Mission SEMPER FEDILIS prime and foremost mission is to protect consumers' health and wellbeing. SEMPER FEDILIS believe that each patient consumes medicines with trust and confidence for their wellbeing. In order to serve better in Domestic and International markets, SEMPER FEDILISendeavour is to utilize team’s full potential to innovate new medications which will open new paradigm in Pharmaceuticals industry.
Factor affecting the global pharma industry There are many factors affecting the global pharma industry such as increasing pace of branded products losing patent exclusivity in developed markets. Much of this phenomenon has impacted mass market and small molecule products. Generic companies around the world including Indian companies have and will continue to reap the benefits of this trend. One more opportunity that is opening up for Indian pharma majors is the beginning of the trend of more complex biologic products losing patent exclusivity in developed markets. This phenomenon is likely to significantly expand the opportunities for many Indian pharma companies with strong international operations. Now, Pharma exports from India are nearly as large as the domestic pharma market. As this international business for India pharma majors grows, companies are gearing up fast to further strengthen their internal capabilities and to manage these international businesses through a mix of strong local affiliate presence along with the strong centralised capabilities, often located and/or managed from India.
Factor affecting the global pharma industry SEMPER FEDILIS objective is to become world class pharmaceutical manufacturer in India as well in the world.SEMPER FEDILIS scientific research and development teams have discovered and produced some of the most widely used medicines.